Among these, 16 immune cell phenotypes, including CD11c+ monocyte % monocyte, are regarded as risk factors for pancreatic cancer (Supplementary Figure 1), while 11 immune cell phenotypes, such as CD4 Treg AC are regarded as protective factors for pancreatic cancer (Supplementary Figure 2). Here, ITGAX is linked to familial pancreatic carcinoma.